Tag:
Recentin
Latest Headlines
Latest Headlines
AZ colon cancer drug is a bust in PhIII
AstraZeneca ( NYSE: AZN ) has been handed another setback in its quest to come up with some major new products quickly. Researchers say that their latest Phase III clinical trial of Recentin as a
AZ's Recentin flunks head-to-head trial with Avastin
AstraZeneca says that its experimental oncology drug Recentin flunked a late-stage, head-to-head showdown with Avastin as a treatment for colon cancer. But the European drug company says that it will
